Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Trulieve Cannabis (TCNNF) EPS (Weighted Average and Diluted) (2020 - 2025)

Trulieve Cannabis has reported EPS (Weighted Average and Diluted) over the past 6 years, most recently at -$0.23 for Q4 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at -$0.23 for Q4 2025, up 14.81% from a year ago — trailing twelve months through Dec 2025 was -$0.57 (up 27.85% YoY), and the annual figure for FY2025 was -$0.58, up 26.58%.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.23 at Trulieve Cannabis, down from -$0.11 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for TCNNF hit a ceiling of $0.31 in Q2 2021 and a floor of -$1.8 in Q2 2023.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was -$0.16 (2022), compared with a mean of -$0.22.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): tumbled 4800.0% in 2021 and later surged 97.78% in 2024.
  • Trulieve Cannabis' EPS (Weighted Average and Diluted) stood at -$0.47 in 2021, then soared by 31.91% to -$0.32 in 2022, then soared by 40.63% to -$0.19 in 2023, then plummeted by 42.11% to -$0.27 in 2024, then rose by 14.81% to -$0.23 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were -$0.23 (Q4 2025), -$0.11 (Q3 2025), and -$0.07 (Q2 2025) per Business Quant data.